EP3280795
COMBINATION OF CHIMERIC ANTIGEN RECEPTOR THERAPY AND AMINO PYRIMIDINE DERIVATIVES
:
EP einkaleyfi: Þýðing ekki lögð inn:
7.4.2016:
24.3.2021:
16718786.3
:
6.4.2036
:
COMBINATION OF CHIMERIC ANTIGEN RECEPTOR THERAPY AND AMINO PYRIMIDINE DERIVATIVES
7.4.2016
24.3.2021
:
Novartis AG:
Lichtstrasse 35, 4056 Basel, CH
:
The Trustees of The University of Pennsylvania:
3160 Chestnut Street Suite 200, Philadelphia, PA 19104, US
:
BYRD, John:
Columbus, OH 43212, US
:
DUBOVSKY, Jason:
Columbus, OH 43235, US
:
JOHNSON, Amy:
Dublin, OH 43016, US
:
JUNE, Carl, H.:
Merion Station, PA 19066, US
:
MUTHUSAMY, Natarajan:
Galloway, OH, US
:
PORTER, David, L.:
Springfield, PA 19064, US
:
WASIK, Mariusz:
Ardmore, PA 19003, US
:
ANGST, Daniela:
4002 Basel, CH
:
FRAIETTA, Joseph, A.:
Williamstown, NJ 08094, US
:
GESSIER, Francois:
4002 Basel, CH
:
GILL, Saar:
Philadelphia, PA 19106, US
:
MAUS, Marcela:
Lexington, MA 02421, US
:
RUELLA, Marco:
Philadelphia, PA 19143, US
:
VULPETTI, Anna:
4002 Basel, CH
:
201562144188 P:
7.4.2015:
US
:
US2016026437:
7.4.2016
:
A61K 31/505, A61K 31/506, A61K 45/06, A61P 35/00, A61P 35/02